> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Awards $1.1 Million Immunoinformatics Contract
- URL: https://www.fdaweb.com/fda-awards-1-1-million-immunoinformatics-contract/
- Published: 2020-10-22T12:00:00.000Z
- Updated: 2026-09-14T16:33:43.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5147931

The CDER Office of Generic Drugs has awarded a two-year $1.1 million contract to EpiVax and CUBRC to continue research performed during a previous two-year collaboration. EpiVax [says](https://finance.yahoo.com/news/fda-awards-1-1m-contract-130000260.htmlhttps:/finance.yahoo.com/news/fda-awards-1-1m-contract-130000260.html?ref=fdaweb.com) that in the previous contract period it demonstrated the value of *in silico* tools and *in vitro* validation methods for evaluating generic peptide drugs and their impurities. EpiVax says it analyzed the immunogenic risk of two generic peptide drugs, applying the concepts outlined in a 2017 FDA draft guidance.